Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Interest Expense - Others (2016 - 2022)

BioRestorative Therapies (BRTX) has disclosed Interest Expense - Others for 7 consecutive years, with $46613.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Interest Expense - Others fell 90.81% year-over-year to $46613.0, compared with a TTM value of $784984.0 through Jun 2022, down 61.12%, and an annual FY2021 reading of $1.8 million, up 10.68% over the prior year.
  • Interest Expense - Others was $46613.0 for Q2 2022 at BioRestorative Therapies, up from $29011.0 in the prior quarter.
  • Across five years, Interest Expense - Others topped out at $1.3 million in Q4 2020 and bottomed at $24168.0 in Q2 2020.
  • Average Interest Expense - Others over 5 years is $306339.7, with a median of $270272.5 recorded in 2018.
  • The sharpest move saw Interest Expense - Others crashed 92.63% in 2020, then surged 1999.19% in 2021.
  • Year by year, Interest Expense - Others stood at $283247.0 in 2018, then surged by 51.18% to $428225.0 in 2019, then skyrocketed by 200.65% to $1.3 million in 2020, then tumbled by 83.39% to $213815.0 in 2021, then tumbled by 78.2% to $46613.0 in 2022.
  • Business Quant data shows Interest Expense - Others for BRTX at $46613.0 in Q2 2022, $29011.0 in Q1 2022, and $213815.0 in Q4 2021.